How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

Senate Republicans had signaled that they would reject Mhim over concerns about his fitness to hold such an important ...

In an interview with the conservative talk show host Hugh Hewitt, President Trump expanded his threat to revoke the ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Enter SuperThin, a cutting-edge dietary supplement that leverages the power of grapefruit extract and other bile-thinning ...

The Daily Mirror runs with an exclusive on the alleged row between David and Victoria Beckham and their son Brooklyn and his ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Rentokil has also replaced two current non-executive directors with Leanne Sheraton, former chief marketing officer at Paypal ...

It already contracts with state inspectors for some of that work and would now do so to cover ... a copy of the 64-page document, dated April 10. The draft is the result of discussions between HHS and ...

While medication and other treatments are out of reach for many, I’ve recently learned TennCare is exploring adding coverage ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

For the last 20 years, I was a successful store manager, responsible ... my health insurance doesn’t cover them. If I could move forward with the obesity treatment options my doctor and I ...